Merit Medical Systems

Merit Medical Systems

MMSI· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -8.9% in FY2025

Fred P. Lampropoulos is the CEO of Merit Medical Systems and was paid $13.8M in FY2025 (Dec), up 32%.

Pay$100 in the stock at the end of FY20 → $145
CEO pay is from each Merit Medical Systems proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1Fred P. LampropoulosFY2025
  2. 2Martha G. AronsonFY2025
  3. 3Raul ParraFY2025
  4. 4Brian G. LloydFY2025
  5. 5Neil W. PetersonFY2025
  6. 6Michel J. VoigtFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Merit Medical Systems paid its 6 named executives $37.2M in total in FY2025 (Dec). CEO Fred P. Lampropoulos was paid $13.8M of that.

Name
Fred P. LampropoulosFormer Chair of the Board, CEO and President
Martha G. AronsonPresident and Chief Executive OfficerNot disclosedNot disclosed
Raul ParraChief Financial Officer and Treasurer
Brian G. LloydChief Legal Officer, Corporate Secretary
Neil W. PetersonChief Operating Officer
Michel J. VoigtChief Human Resources OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2025 (Dec) proxy of Merit Medical Systems names 16 peer companies for pay. Among Merit Medical Systems and these peers, CEO pay was 4th highest of 6 and total shareholder return was 2nd highest of 6.

4th highest of 6in Merit Medical Systems and its pay peers, FY2025 (Dec) by CEO pay:

$851.6K$18.9M

2nd highest of 6in Merit Medical Systems and its pay peers, FY2025 (Dec) by total shareholder return:

$49$178

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Fred P. LampropoulosChair · 37 yr on the boardNot independent—Paid as an executive

The board of the latest proxy (FY2024).

Activity

  1. Pay
    Merit Medical Systems CFO pay rose 52% to $4.8M. The stock fell 9% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Merit Medical Systems COO pay rose 31% to $4.1M. The stock fell 9% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Merit Medical Systems CEO pay rose 32% to $13.8M. The stock fell 9% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Merit Medical Systems General counsel pay rose 43% to $4.4M. The stock fell 9% in FY2025 (Dec).
    DEF 14A
  5. Pay
    Merit Medical Systems CFO pay rose 14% to $3.2M. The stock rose 27% in FY2024 (Dec).
    DEF 14A
  6. Pay
    Merit Medical Systems COO pay rose 16% to $3.1M. The stock rose 27% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Merit Medical Systems Former President pay rose 20% to $3.4M. The stock rose 27% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Merit Medical Systems General counsel pay rose 17% to $3.1M. The stock rose 27% in FY2024 (Dec).
    DEF 14A
  9. Pay
    Merit Medical Systems CFO pay rose 48% to $2.5M. The stock rose 13% in FY2022 (Dec).
    DEF 14A
  10. Pay
    Merit Medical Systems COO pay rose 89% to $2.7M. The stock rose 8% in FY2023 (Dec).
    DEF 14A
  11. Pay
    Merit Medical Systems Former President pay rose 51% to $2.8M. The stock rose 8% in FY2023 (Dec).
    DEF 14A
  12. Pay
    Merit Medical Systems Former President pay rose 13% to $1.9M. The stock rose 13% in FY2022 (Dec).
    DEF 14A
  13. Pay
    Merit Medical Systems CEO pay rose 24% to $10.1M. The stock rose 8% in FY2023 (Dec).
    DEF 14A
  14. Pay
    Merit Medical Systems General counsel pay rose 53% to $2.7M. The stock rose 8% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AMar 31, 2026FY2025
Annual report10-KFeb 24, 2026FY2025
Proxy statementDEF 14AApr 1, 2025FY2024
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 2, 2024FY2023
Annual report10-KFeb 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data